Hey Guys, yesterday's video for your entertainment. If you like please subscribe. If you dont I apologize and will try harder. Thanks.
I made a fool of myself today for you guys to try and help lift your spirits. If you like please subscribe if not I'll do an better one tomorrow.
Hey, Fat Cash, if I may be your de facto director on this one, nice to see you getting creative and reporting from the future. Next time hire a few hot babes in bikinis as extras by the pool. You'll increase your likes a hundred fold. Also, it would be nice to hear some company news once in a while. See below. Relief Reports Half-Year 2020 Results 1:30 am ET September 15, 2020 (Accesswire) Print GENEVA, SWITZERLAND / ACCESSWIRE / September 15, 2020 / RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100 (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced its results for the half year ended June 30, 2020. Operative Highlights Year to Date 2020: RLF-100: US Phase IIb/III trial in severe COVID-19-induced Acute Respiratory Distress Syndrome ("ARDS") initiated; in July 2020, Data Safety Monitoring Board interim safety/futility analysis of 30 patients recommended study continue as planned. In August 2020, promising results reported from the first 21 patients treated with RLF-100 under FDA Expanded Access Protocol authorization. Topline results expected in early-4th quarter 2020.US Food and Drug Administration ("FDA") granted Emergency Use Investigational New Drug ("IND") authorization and Expanded Access Protocol authorization granted for treatment of respiratory failure in COVID-19.Fast track designation granted by FDA for acute lung injury/ARDS associated with COVID-19. FDA IND granted to test inhaled formulation in patients with moderate and severe COVID-19 to prevent progression to respiratory failure. Further details are available in Relief's Half Year 2020 Report, which is available for download at https://relieftherapeutics.com/key-information/.
CUT! Bring in wardrobe. We'll have to clear it with the union if you're gonna take your shirt off, Fat Cash. Need to keep the G rating.
I was skeptical. But now seeing The Foot topless, I am all in. Skin sealed the deal. Sex sells. Not 1 lady on this forum can say that she wasn't tittillated. As a man, I got jealous. I immediately fell to the floor, cranked out 4 Joe Biden pushups, ran to the bathroom, ripped off my cardigan, and checked to see if my own chest and shoulders looked as good.
oddly enough, you look similar to an actor friend of mine (see waiter in video below) who lives about a mile away and is in most of my short films. Being that you are 2500 miles away it doesn't seem feasible that we could work together. however, when your stock does what you say it is going to do and money is no object, then let's talk.
they have a drug that they are pushing for the government to approve for emergency use. The drug itself is not specifically developed for Covid. It is an existing drug which was engineered for another use. It was designed for erectile dysfunction. Although I have never heard of it, since Viagra is the drug more commonly prescribed. But who am I to doubt that a 3rd rate pecker pill will save.The world? Remdesivir, which was also repurposed for Covid use, was approved months ago because it was proven effective. RLFTF has studied 51 people since February. Apparently, doctors worldwide have not sought out RLFTF.
